The Impact of Methadone Maintenance Therapy on Food Reward Processing in Opioid Dependence

Overview

Methadone maintenance therapy (MMT) has shown clear efficacy for relieving opioid withdrawal symptoms and reducing the morbidity and mortality of opioid dependence. A notable phenomenon associated with MMT is increased food intake, enhanced sweet preferences, and weight gain. The underlying neural mechanisms for opioid-related overconsumption are not well understood but are thought to arise from role in 1) increasing the palatability and hedonic aspects of food and 2) diminishing satiety signaling systems. In the proposed project, the investigators will examine methadone's potential role in opioid-related overconsumption of food. The investigators propose to examine eating behavior, sucrose preferences, and an event-related potential (ERP) component that is induced by appetitive motivation for highly rewarding foods in patients with a history of opioid dependence receiving methadone maintenance therapy (O+MMT) and not receiving opioid agonist therapy (O-MMT). A matched sample of obese and overweight adults without history of opioid use (HOC) will also be examined.

Full Title of Study: “The Impact of Methadone Maintenance Therapy on Food Intake and Food Reward Processing in Opioid Dependence: An Event-related Brain Potential Study”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Non-Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Basic Science
    • Masking: None (Open Label)
  • Study Primary Completion Date: December 1, 2019

Detailed Description

Methadone maintenance therapy (MMT) has shown clear efficacy for relieving opioid withdrawal symptoms and reducing the morbidity and mortality of opioid dependence. A notable phenomenon associated with MMT is increased food intake, enhanced sweet preferences, and weight gain. The underlying neural mechanisms for opioid-related overconsumption are not well understood but are thought to arise from role in 1) increasing the palatability and hedonic aspects of food and 2) diminishing satiety signaling systems. In the proposed project, the investigators will examine methadone's potential role in opioid-related overconsumption of food. The investigators propose to examine eating behavior, sucrose preferences, and an event-related potential (ERP) component that is induced by appetitive motivation for highly rewarding foods in patients with a history of opioid dependence receiving methadone maintenance therapy (O+MMT) and not receiving opioid agonist therapy (O-MMT). A matched sample of obese and overweight adults without history of opioid use (HOC) will also be examined. Specifically, group differences in food intake and eating behaviors in the O+MMT group relative to individuals in the O-MMT and HOC group will be examined. Individuals will complete 24-hour dietary food recalls and inventories to characterize eating behavior and food addiction. Participants will complete psychophysical measures of chemosensory functioning of sucrose preference and pleasantness and identification ratings for odors varying in participants' hedonic characteristics. Individuals will also complete validated computer tasks to assess food preferences. Differences in cortical ERPs for high-reward food relative to low-reward food and non-food items will be examined. Event-related potentials will be recorded as participants view photos of rewarding and non-rewarding food items, as well as non-food items. ERP components that index sustained attentional engagement will be measured and compared.

Interventions

  • Behavioral: Sniffin’ Sticks Odor Identification and Hedonic Scale
    • This task measures odor identification accuracy and perceived pleasantness of odors.
  • Behavioral: Sucrose Taste Preference Assessment
    • This task measures participant ratings of sucrose preference.
  • Behavioral: Food Preferences Task
    • Participants rate images of various food stimuli. Variables derived include relative preferences and reaction time (in milliseconds).
  • Behavioral: Progressive Ratio (PR) Task
    • In the PR task, the subject is required to make an increasing number of operant responses for each successive reward
  • Procedure: Clinical Electrophysiology
    • To examine motivated attention in response to food stimuli, brain electrophysiology via event related potentials (ERPs) will be assessed while participants view and rate images of food and non-food items.
  • Dietary Supplement: Standardized Meal and Hunger and Satiety Ratings
    • Participants will receive a standardized meal and complete hunger and satiety ratings.

Arms, Groups and Cohorts

  • Experimental: Opioid dependence receiving methadone
    • Patients with a history of opioid dependence receiving methadone maintenance therapy will be administered Sniffin’ Sticks Odor Identification and Hedonic Scale, Sucrose Taste Preference Assessment, Food Preferences Task, Progressive Ratio Task, Clinical Electrophysiology, and Standardized Meal and Hunger and Satiety Ratings
  • Experimental: Opioid dependence not on methadone
    • Patients with a history of opioid dependence not current receiving methadone maintenance therapy will be administered Sniffin’ Sticks Odor Identification and Hedonic Scale, Sucrose Taste Preference Assessment, Food Preferences Task, Progressive Ratio Task, Clinical Electrophysiology, and Standardized Meal and Hunger and Satiety Ratings
  • Active Comparator: Healthy controls
    • Healthy controls without history of opioid use will be administered Sniffin’ Sticks Odor Identification and Hedonic Scale, Sucrose Taste Preference Assessment, Food Preferences Task, Progressive Ratio Task, Clinical Electrophysiology, and Standardized Meal and Hunger and Satiety Ratings

Clinical Trial Outcome Measures

Primary Measures

  • Event-related potentials measured via BrainVision actiCHamp system
    • Time Frame: At baseline visit
    • Cortical ERPs for high-reward food relative to low-reward food and non-food items will be measured using a BrainVision actiCHamp system (32-channel amplifier). For each group, the grand averages and standard deviations for the late positive potential will be calculated. Group differences in LPP will be assessed within and between picture categories for each arm of the study.

Secondary Measures

  • Chemosensory Processing
    • Time Frame: At baseline visit
    • For the odorants, participants provide a rating of intensity and pleasantness based on a -5 to 5 point scale for each of the 16 markers. Afterwards, averages of all 16 marker scores will be calculated for the mean ratings of intensity and pleasantness. Odor identification accuracy will be assessed for each marker, with the score representing the total items correct out of 16.
  • Food Preferences Task
    • Time Frame: At baseline visit
    • Participants are showed images of high fat savory, low fat savory, high fat sweet, and low fat sweet foods. Participants must select one of the two pictures to answer the question “which food item do you most want to eat right now.” Selection averages of each category and time for selection, for each arm of the study, are automatically calculated by E-Prime software.
  • Progressive Ratio Task
    • Time Frame: At baseline visit
    • Participants begin with 20 M&Ms and a computer prompt that specifies how many times the mouse must be clicked to earn a piece of candy. Participants can earn as little as desired. The click ratio starts at 10 and geometrically increases in increments of 2 (i.e., 10, 20, 40, 80, etc.). The computer program E-Prime automatically records the participant’s work capacity and the administrator records the number of M&Ms left in the cup.

Participating in This Clinical Trial

Inclusion Criteria

  • English-speaking individuals – Must be between 18 and 60 years of age – For the O+MMT group, participants must be receiving MMT for at least 3 months – For the O-MMT group, participants must have concluded their MMT (if applicable) at least three months prior to the date of the screening visit. Exclusion criteria:

  • Individuals may not have a history of major neurological disorders – No unstable medical issues that would affect appetite or blood glucose – No pervasive developmental disorder or intellectual disability – No significant visual/auditory impairment – No history or current episode of psychosis – No current opioid abuse – No current antipsychotic medication use – No major conditions that affect chemosensory function (e.g., history of nasal fracture or respiratory infection) – Individuals with contraindication for the EEG will be excluded – Individuals who are current pregnant or breastfeeding will not be enrolled – For HOC, individuals with history of opioid dependence or current or past psychiatric disorders will be excluded

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 60 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Johns Hopkins University
  • Collaborator
    • Mid-Atlantic Nutrition Obesity Research Center
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Vidya Kamath, Ph.D., Principal Investigator, Johns Hopkins University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.